Looking forward to the next few months. Once this set of trials has reported top line data for prurisol, brilacidin and kevetrin I doubt there will be anything stopping us. Consider the trial designs and continued success. If everything goes as we expect the potential for successful phase 3 trials is huge. I know I'm writing what everyone already knows. But doing the DD and realizing the potential isn't what the passerby does. Look at the MOA's and the efficacy to date, weigh it and measure it.
I'll just say, there's a reason why this is one of my largest holdings. Hyperlinked...
News 
Market Data 
Discover 
